Skip to content

Moderna Inc Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: November 6, 2026 results vs estimates

Moderna Inc · E.MRNA.NASDAQ · United States
Use symbol E.MRNA.NASDAQ in our API & Excel add-in to retrieve this data ↓
222.76
(+0.04%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 106.90%

Moderna Inc Forecast

Moderna Inc short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 106.9% a year, a typical one-standard-deviation range is 189.22–256.30 over a week, 154.02–291.50 over a month and -15.37–460.89 over a year. (Signals as of 1 Nov 2026.)

Moderna Inc Price Chart

MacroFinance.ai
Market/MacroIndicatorNowChangeRange
Quantitative
Moderna Inc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Moderna Inc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Moderna Inc
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Moderna Inc
P/S
37.94x
Stretched vs own history
QoQ +46.3%
YoY +810.8%
now 37.93544.56 low43.29 high
ⓘP/S As of 22 Nov 2026.See Moderna Inc returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Moderna Inc
P/B
14.01x
Stretched vs own history
QoQ +64.0%
YoY +1,313.0%
now 14.01011.09 low15.99 high
ⓘP/B As of 22 Nov 2026.See Moderna Inc returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Moderna Inc
EV/Sales
37.54x
Stretched vs own history
QoQ +55.2%
YoY +1,258.1%
now 37.54253.16 low42.89 high
ⓘEV/Sales As of 22 Nov 2026.See Moderna Inc returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Moderna Inc
FCF Yield
-2.1%
Mid-range vs own history
QoQ −4.5%
YoY −92.9%
now -2.0567-26.28 low-1.39 high
ⓘFCF Yield As of 22 Nov 2026.See Moderna Inc returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Moderna Inc
Earnings Yield
-2.9%
Mid-range vs own history
QoQ −46.6%
YoY −91.4%
now -2.9117-30.75 low-2.55 high
ⓘEarnings Yield As of 22 Nov 2026.See Moderna Inc returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Moderna Inc
Market Cap
$95.8B
Highest in 5 years
QoQ +65.8%
YoY +935.4%
now 95786.810,132 low109,302 high
ⓘMarket Cap As of 22 Nov 2026.See Moderna Inc returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Moderna Inc
Net Debt
-$992M
High vs own history
QoQ −74.2%
YoY −68.1%
now -992-4,494 low-992 high
ⓘNet Debt As of 22 Nov 2026.See Moderna Inc returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Moderna Inc
Current Ratio
3.62x
Mid-range vs own history
QoQ +57.8%
YoY −7.7%
now 3.62132.29 low3.93 high
ⓘCurrent Ratio As of 22 Nov 2026.See Moderna Inc returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Moderna Inc
Quick Ratio
3.47x
Mid-range vs own history
QoQ +58.7%
YoY −7.0%
now 3.4672.18 low3.73 high
ⓘQuick Ratio As of 22 Nov 2026.See Moderna Inc returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Moderna Inc
Interest Coverage
-45.20x
Mid-range vs own history
QoQ −38.2%
YoY −88.5%
now -45.2-393.13 low-45.2 high
ⓘInterest Coverage As of 22 Nov 2026.See Moderna Inc returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Moderna Inc
Debt / Equity
0.61x
High vs own history
QoQ +221.1%
YoY +309.1%
now 0.61120.15 low0.61 high
ⓘDebt / Equity As of 22 Nov 2026.See Moderna Inc returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Moderna Inc
Piotroski F-Score
4
Mid-range vs own history
QoQ +300.0%
YoY +100.0%
now 41 low4 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Moderna Inc returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Moderna Inc
Altman Z-Score
9.21
Strong vs own history
QoQ +7.8%
YoY +238.5%
now 9.21062.91 low13.08 high
ⓘAltman Z-Score As of 22 Nov 2026.See Moderna Inc returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  18 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  19 members-only factors: Sloan Accruals, Cash-Earnings Gap, Days Sales in Receivables Index, Gross Margin Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Moderna Inc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Moderna Inc fundamentals: income statement, balance sheet & cash flow

Moderna Inc reported revenue of $1.94bn and net income of -$2.82bn in FY2025, the year ended 31 December 2025 — revenue down 39.2% and net income up 20.8% on the prior year. Free cash flow was -$2.07bn. These figures are as reported in the filings, not restated: 12 fiscal years and 40 quarters of history, back to December 2014. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$1.94bn
-39.2%
Net income
-$2.82bn
+20.8%
Gross margin
55.35%
Free cash flow
-$2.07bn
+49.1%
Net debt
-$1.29bn
Shares short (30 Oct 2026)
33.19m
1.76 days to cover
Moderna Inc income statement, annual, as reported · USD billions unless stated
USD billionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue1.943.206.8518.8817.74
Cost of revenue0.871.464.695.422.62
Gross profit1.081.742.1613.4615.12
Research & development3.134.544.853.301.99
Selling, general & admin.1.02————
Operating income-3.07-3.95-4.249.4213.30
EBITDA-2.55-3.39-3.289.9513.53
Interest expense0.010.020.040.030.02
Pre-tax income-2.77-3.61-3.949.5813.29
Income tax0.05-0.050.771.211.08
Net income-2.82-3.56-4.718.3612.20

Download Moderna Inc fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.MRNA.NASDAQ&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 12 fiscal years, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Moderna Inc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Moderna Inc Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Moderna Inc; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Moderna Inc’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Moderna Inc behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Moderna Inc (United States)

Moderna Inc is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Moderna Inc?
Moderna Inc is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Moderna Inc price?
The latest close is 222.76 (1 Nov 2026), +0.04% on the day. The price at the top of the page refreshes during the trading day.
Is Moderna Inc in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Moderna Inc?
20-day realised volatility is 106.9% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 30.9% over a month and 15.1% over a week.
What factors affect Moderna Inc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Moderna Inc, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Moderna Inc?
58 backtested tactical asset allocation strategies trade Moderna Inc through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Moderna Inc returns analysed?
The Statistical Distribution of Returns section shows the distribution of Moderna Inc daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Moderna Inc historical data?
In the Free historical data section of this page: the last 10 years of Moderna Inc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Moderna Inc historical data (last 10 years)

Browse or instantly download the last 10 years of Moderna Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.MRNA.NASDAQ&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20195
2026-11-19199.33
2026-11-18196.79
2026-11-17206.8
2026-11-16215.27
2026-11-13223.37
2026-11-12231.35
2026-11-11248.69
2026-11-10250.83
2026-11-09269
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.